Trust Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6M Sell
18,839
-463
-2% -$473K 10.79% 1
2026
Q1
$17.8M Sell
19,302
-923
-5% -$936K 10.39% 1
2025
Q4
$21.7M Sell
20,225
-568
-3% -$543K 11.57% 1
2025
Q3
$15.9M Buy
20,793
+10
+0% +$7.44K 8.92% 2
2025
Q2
$16.2M Sell
20,783
-1,277
-6% -$992K 9.83% 1
2025
Q1
$18.2M Buy
22,060
+672
+3% +$559K 11.73% 1
2024
Q4
$16.5M Buy
21,388
+311
+1% +$258K 10.54% 2
2024
Q3
$18.7M Sell
21,077
-845
-4% -$760K 11.9% 1
2024
Q2
$19.8M Buy
21,922
+4,536
+26% +$3.63M 12.62% 1
2024
Q1
$13.5M Sell
17,386
-196
-1% -$139K 9.76% 1
2023
Q4
$10.2M Sell
17,582
-529
-3% -$309K 7.99% 2
2023
Q3
$9.73M Sell
18,111
-597
-3% -$308K 8.37% 1
2023
Q2
$8.77M Buy
18,708
+539
+3% +$226K 7.08% 2
2023
Q1
$6.24M Sell
18,169
-1,075
-6% -$363K 5.59% 3
2022
Q4
$7.04M Buy
19,244
+515
+3% +$183K 6.64% 2
2022
Q3
$6.06M Sell
18,729
-900
-5% -$285K 6.32% 2
2022
Q2
$6.36M Buy
19,629
+1,734
+10% +$520K 6.11% 2
2022
Q1
$5.12M Sell
17,895
-53
-0.3% -$13.6K 4.17% 3
2021
Q4
$4.96M Buy
17,948
+89
+0.5% +$22.6K 3.91% 3
2021
Q3
$4.13M Sell
17,859
-1,167
-6% -$288K 3.69% 3
2021
Q2
$4.37M Buy
19,026
+28
+0.1% +$5.62K 3.86% 3
2021
Q1
$3.55M Sell
18,998
-1,648
-8% -$322K 3.48% 3
2020
Q4
$3.49M Sell
20,646
-64
-0.3% -$9.56K 3.53% 3
2020
Q3
$3.06M Hold
20,710
3.56% 3
2020
Q2
$3.4M Sell
20,710
-300
-1% -$46K 4.36% 3
2020
Q1
$2.92M Sell
21,010
-700
-3% -$96.2K 4.83% 3
2019
Q4
$2.85M Sell
21,710
-200
-0.9% -$23.2K 3.55% 3
2019
Q3
$2.45M Sell
21,910
-700
-3% -$77.9K 3.17% 3
2019
Q2
$2.5M Sell
22,610
-1,925
-8% -$227K 3.15% 4
2019
Q1
$3.18M Sell
24,535
-400
-2% -$48.6K 3.75% 3
2018
Q4
$2.88M Sell
24,935
-300
-1% -$33.5K 3.64% 3
2018
Q3
$2.71M Sell
25,235
-25
-0.1% -$2.5K 2.78% 4
2018
Q2
$2.15M Sell
25,260
-200
-0.8% -$16.4K 2.37% 5
2018
Q1
$1.97M Sell
25,460
-1,300
-5% -$105K 2.26% 4
2017
Q4
$2.26M Sell
26,760
-811
-3% -$69K 2.51% 4
2017
Q3
$2.36M Sell
27,571
-4,456
-14% -$365K 2.67% 4
2017
Q2
$2.64M Buy
32,027
+92
+0.3% +$7.51K 2.83% 3
2017
Q1
$2.69M Sell
31,935
-505
-2% -$40.4K 2.89% 3
2016
Q4
$2.39M Sell
32,440
-275
-0.8% -$20.5K 2.71% 3
2016
Q3
$2.63M Sell
32,715
-810
-2% -$64.8K 2.99% 3
2016
Q2
$2.64M Sell
33,525
-1,200
-3% -$90.3K 3.11% 3
2016
Q1
$2.5M Sell
34,725
-1,800
-5% -$136K 2.82% 3
2015
Q4
$3.08M Sell
36,525
-2,234
-6% -$185K 3.71% 3
2015
Q3
$3.24M Sell
38,759
-800
-2% -$67.5K 3.68% 2
2015
Q2
$3.3M Sell
39,559
-32
-0.1% -$2.44K 3.36% 3
2015
Q1
$2.88M Sell
39,591
-400
-1% -$28.5K 2.86% 3
2014
Q4
$2.76M Sell
39,991
-1,743
-4% -$118K 2.81% 3
2014
Q3
$2.71M Sell
41,734
-1,600
-4% -$101K 2.61% 3
2014
Q2
$2.69M Buy
43,334
+1,450
+3% +$86.5K 2.59% 3
2014
Q1
$2.46M Buy
41,884
+2,408
+6% +$134K 2.48% 3
2013
Q4
$2.01M Buy
+39,476
New +$1.98M 2.08% 3

Other funds holding LLY

Trust Investment Advisors's LLY Position: Q2 2026 in Review

Trust Investment Advisors reduced its Eli Lilly (LLY) stake by 2.4% in Q2 2026, selling an estimated $473K and leaving 18,839 shares worth $22.6M. The position accounts for 10.79% of the portfolio, ranked #1.

Trust Investment Advisors first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Trust Investment Advisors held 18,839 shares of Eli Lilly worth $22.6M as of Q2 2026.
  • Trust Investment Advisors sold 463 Eli Lilly shares in Q2 2026, an estimated $473K.
  • Eli Lilly made up 10.79% of Trust Investment Advisors's portfolio in Q2 2026, its #1 holding.
  • Trust Investment Advisors first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Trust Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.